Back
Insight Molecular Diagnostics Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
30
IMDX
Insight Molecular Diagnostics
Last Price:
$2.94
Seasonality Move:
-2.21%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IMDX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Insight Molecular Diagnostics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.89 | Sell |
20-day SMA: | 3.13 | Sell |
50-day SMA: | 3.02 | Sell |
200-day SMA: | 2.82 | Buy |
8-day EMA: | 2.36 | Buy |
20-day EMA: | 1.44 | Buy |
50-day EMA: | 0.7 | Buy |
200-day EMA: | 0.19 | Buy |
Insight Molecular Diagnostics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.78 | Buy |
Relative Strength Index (14 RSI): | 44.42 | Sell |
Chaikin Money Flow: | 9980 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.7 - 3.4) | Sell |
Bollinger Bands (100): | (2.72 - 3.44) | Sell |
Insight Molecular Diagnostics Technical Analysis
Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Insight Molecular Diagnostics Stock
Is Insight Molecular Diagnostics Stock a Buy?
-
Insight Molecular Diagnostics share price is 2.83 while IMDX 8-day simple moving average is 2.89, which is a Sell signal.
-
The stock price of IMDX is 2.83 while Insight Molecular Diagnostics 20-day SMA is 3.13, which makes it a Sell.
-
Insight Molecular Diagnostics 50-day simple moving average is 3.02 while IMDX share price is 2.83, making it a Sell technically.
-
IMDX stock price is 2.83 and Insight Molecular Diagnostics 200-day simple moving average is 2.82, creating a Buy signal.
IMDX Technical Analysis vs Fundamental Analysis
Sell
30
Insight Molecular Diagnostics (IMDX)
is a Sell
Is Insight Molecular Diagnostics a Buy or a Sell?
-
Insight Molecular Diagnostics stock is rated a SellThe current Insight Molecular Diagnostics [IMDX] share price is $2.83. The Score for IMDX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
Insight Molecular Diagnostics Stock Info
Market Cap:
80.9M
Price in USD:
2.83
Share Volume:
20K
Insight Molecular Diagnostics 52-Week Range
52-Week High:
4.75
52-Week Low:
1.92
Sell
30
Insight Molecular Diagnostics (IMDX)
is a Sell
Insight Molecular Diagnostics Share Price Forecast
-
What is the Insight Molecular Diagnostics stock price today?The Insight Molecular Diagnostics stock price is 2.83 USD today.
-
Will IMDX stock go up or go down?Insight Molecular Diagnostics> share price is forecast to RISE/FALL based on technical indicators
-
Is Insight Molecular Diagnostics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Insight Molecular Diagnostics is overvalued.
Is Insight Molecular Diagnostics Stock a Buy?
-
Insight Molecular Diagnostics share price is 2.83 while IMDX 8-day exponential moving average is 2.36, which is a Buy signal.
-
The stock price of IMDX is 2.83 while Insight Molecular Diagnostics 20-day EMA is 1.44, which makes it a Buy.
-
Insight Molecular Diagnostics 50-day exponential moving average is 0.70 while IMDX share price is 2.83, making it a Buy technically.
-
IMDX stock price is 2.83 and Insight Molecular Diagnostics 200-day simple moving average is 0.19, creating a Buy signal.
Fundamental Analysis of Insight Molecular Diagnostics
Is Insight Molecular Diagnostics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.03 per share.
Technical Analysis of Insight Molecular Diagnostics
Should I short Insight Molecular Diagnostics stock?
-
IMDX Moving Average Covergence Divergence (MACD) indicator is 0.78, suggesting Insight Molecular Diagnostics is a Buy
-
Insight Molecular Diagnostics Relative Strength Index (RSI) is 44.42, which suggest Insight Molecular Diagnostics is oversold
-
The Bollinger Bands (25) for Insight Molecular Diagnostics is (2.7 - 3.4), which suggest Insight Molecular Diagnostics is a Sell
-
The Bollinger Bands (100) for Insight Molecular Diagnostics is (2.72 - 3.44), which suggest Insight Molecular Diagnostics is a Sell
* Insight Molecular Diagnostics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.